A corporate obesity program built for the GLP-1 era.
We bring together telemedicine, GLP-1 supply, behavioral monitoring, and outcomes analytics in a single program — designed for companies that manage their own healthcare plans and prefer sustainable weight loss over unsupported medication use.

The context
Nearly 3 in 4 American adults are overweight or obese. Employers are paying the price.
Rising healthcare claims, lower productivity, absenteeism, and escalating chronic disease costs are impacting companies' bottom lines.
GLP-1 medications have changed the equation. Millions of Americans are already using them, and employer-sponsored coverage is expanding rapidly as companies search for better long-term health outcomes.
But access alone is not solving the problem.
Up to 65% of GLP-1 patients discontinue treatment within the first year, often before reaching a stable healthy weight. The result is a costly cycle of dropout, regain, repeat treatment, and recurring claims — with employers absorbing the financial impact throughout the process.
The challenge is no longer whether GLP-1s work.
It's whether employers can turn short-term medication use into durable behavioral change and measurable long-term outcomes.
75%
of American workers are overweight
1 in 8
American adults have used GLP-1 medication
65%
discontinue GLP-1 before reaching their goal
An obesity program is no longer optional infrastructure — it's a measurable line item in your health plan.
What it's for
Four outcomes a corporate obesity program should deliver.
Built around the goals that matter to a self-managed health plan: lower long-term cost, better treatment, fewer side effects, healthier employees.
1.Reduce overweight & obesity sustainably
Cut the long-term burden of chronic disease — hypertension, type 2 diabetes, cardiovascular events — and the healthcare costs that come with it.
2.Protect your primary care budget
Eligible employees are professionally supported from day one, instead of seeking emergency or unplanned primary care for medication side effects.
3.Make GLP-1 treatment actually work
The right patients are selected, supported, and monitored — improving adherence and the real-world weight loss your plan is paying for.
4.Reduce the impact on productivity
Less absenteeism, fewer disruptive side effects at work, and a healthier workforce over time.
The offering
One supplier, one program, one accountable partner.
Companies want a 1-stop shop. We integrate eligibility, telemedicine, medication, logistics, monitoring, and outcomes reporting into a single corporate obesity program — powered by our Sinque platform.
Core program
Medication supply & cold-chain logistics
GLP-1 medication delivered directly to employees' homes, with cold-chain handling and a managed pharmacy partner.
Telemedicine end-to-end
Triage, intake, prescription, and ongoing medical support — including a network of dietitians and nutritionists.
Behavioral monitoring & support
Personal monitor, Sinque app, and clinician dashboard — with personalized support throughout the program.
Program KPI monitoring
Adherence, weight-loss trajectory, dropout risk — visible in a single dashboard for your benefits team.

Adjacent (optional)
Large traffic monitors
On-site weighing stations for offices and plants, integrated into the program data flow.
Program funding facility
Through our liaison OCIP institute, eligible companies can direct up to 1.5% of presumed corporate income tax to fund the program.
Healthcare cost analytics
Data analytics to demonstrate the impact on your future corporate healthcare cost — co-developed with health-insurance broker partners.
Built with the right partners
An ecosystem assembled so you don't have to.

Pharmacy — medication supply & cold-chain logistics

Monitoring technology, predictive behavioral analytics, training & app
Iron Fit
Telemedicine — clinical, nutritional and mental support
Magre3 Corporate
Telemedicine — clinical, nutritional and mental support
Health-insurance broker partners
Medical data analytics and benefits integration
Instituto Brasil Campeão (IBC)
OCIP liaison for tax-funded program structuring
Talk to us
Tell us about your company.
Send us a few details and our team will follow up within one business day to scope a corporate obesity program for your workforce.
